Follow Us
Maintains a "Wide Moat" rating due to its dominance in the drug manufacturing sector. Identified as a top European sector pick for Q1 2026.
Rated a by Zacks Investment Research as of April 2026.
If you prefer broad exposure, Morningstar and U.S. News recommend these highly-rated funds:
Maintains a "Wide Moat" rating due to its dominance in the drug manufacturing sector. Identified as a top European sector pick for Q1 2026.
Rated a by Zacks Investment Research as of April 2026. overseas stocks to buy
If you prefer broad exposure, Morningstar and U.S. News recommend these highly-rated funds: Maintains a "Wide Moat" rating due to its
